The rise of copyright’s blockbuster initially sparked a surge for pharma, but recent changes present a murky picture for those considering a stake. Lower-cost competitors are eroding earnings, and ongoing patent https://majapmpg821300.losblogos.com/39937517/viagra-and-big-pharma-a-precarious-play